AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the tech-enabled drug discovery company today announced it has received an additional €30 million investment, which brings the Series A funding round to €60 million. This...
This launch aims to elevate chest abnormality detection in Samsung's premium X-ray devices and help clinicians provide a more efficient care path for patients
Boston Imaging, the United States headquarters of Samsung’s digital radiography (DR) and ultrasound business, announced that Samsung has signed a supply contract with Lunit Inc., a leading...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, have reached an agreement to define and discover biomarkers within the DNA Damage Repair (DDR) biology space to predict the clinical benefit of one or...
Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules
Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.
“We are pleased to announce Merck as...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, and Translational Genomics Research Institute (TGen), a precision medicine research...
A leading South Korean company providing a total solution for PCR molecular diagnostics, announced its selection of Microsoft as a technology partner for its SG OneSystem™ business in London, UK, on January 23 to realize 'a world free from all diseases.'
Seegene will collaborate with Microsoft to help propel the...
Bionano Genomics, Inc. announced the full commercial release of the Stratys™ system, the Company’s system for high throughput optical genome mapping (OGM).
As part of an early access program, the following 10 sites have adopted a total of 11 Stratys systems:
BC Cancer - Vancouver (Vancouver, British Columbia)
Hamilton Health...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and Executive Board member with immediate effect.
Dr. Joerg Moeller, MD, PhD, brings a wealth of experience to BenevolentAI. During his career, he has led global research...
LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments
Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial intelligence, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
Saama announced the release of several groundbreaking features within its AI-driven platform, including generative AI (GenAI) chat and interactive review listings (IRL), creating an unparalleled, workflow-driven environment for cross-functional collaboration. For the first time, users can ask questions of their data in natural language, and instantly receive responses – eliminating...
